Related Experiment Video
Updated: Apr 28, 2026

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
[Programmed cell death in cancer cells]
Abstract:
Resistance to programmed cell death is one of the hallmarks of cancer cells that affects the process of malignant transformation as well as response to cancer therapy. The goal of this review is to summarize recent information about programmed cell death (PCD) in healthy and cancer cells, as well as new perspectives for anticancer treatments targeting these signaling pathways. Three main types of PCD are described in detail: apoptosis, necrosis/ necroptosis and cell death associated with autophagy. Among them, apoptosis plays the key role in both malignant transformation and response to therapy. In this review, we describe main signaling pathways and molecules participating in apoptosis regulation in healthy cells. In most cancer cells, mutations or aberrant expression of proteins directly or indirectly involved in induction and execution of cell death can be detected - p53, Bcl 2 family proteins, inhibitors of apoptosis, death receptors/ ligands and other proteins. Mutations or changes in expression of these proteins and their relation to certain types of tumors are described. Finally, we provide a review of recently developed treatments that target and reactivate the machinery of programmed cell death and are currently tested in clinical trials.
Insights
Cancer cells resist programmed cell death (PCD), a key factor in tumor development and treatment failure. This review explores PCD pathways and novel therapies targeting cell death to combat cancer.
Area of Science:
- Cell Biology
- Oncology
- Molecular Biology
Context:
- Resistance to programmed cell death (PCD) is a hallmark of cancer, impacting malignant transformation and therapeutic response.
- Understanding the molecular mechanisms of PCD is crucial for developing effective cancer treatments.
Purpose:
- To review current knowledge on programmed cell death (PCD) in healthy and cancerous cells.
- To highlight new perspectives for anticancer treatments targeting PCD signaling pathways.
Summary:
- This review details three main types of PCD: apoptosis, necroptosis, and autophagic cell death, with a focus on apoptosis's critical role.
- It examines signaling pathways and molecules regulating apoptosis in healthy cells and discusses mutations in cancer cells (e.g., p53, Bcl-2 family).
- The review covers recently developed treatments targeting PCD machinery currently in clinical trials.
Impact:
- Provides a comprehensive overview of PCD in cancer biology.
- Identifies key molecular players and their alterations in various tumor types.
- Highlights emerging therapeutic strategies aimed at reactivating cell death pathways for cancer treatment.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Apoptosis
The Intrinsic Apoptotic Pathway
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
The Extrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

